Regencell Bioscience Holdings Ltd — Investor Relations & Filings
Filings indexed
80
across all filing types
Latest filing
2021-12-30
Major Shareholding Noti…
Country
US
United States of America
Listing
US
RGC
Regencell Bioscience Holdings Ltd. is an early-stage bioscience company that focuses on the research, development, and commercialization of proprietary Traditional Chinese Medicine (TCM) formulations. The company's primary therapeutic focus is on treating neurocognitive and neurodevelopmental disorders, specifically Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). It aims to develop natural and effective treatments to improve the quality of life for patients and their families, with the goal of becoming a global market leader in this field.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| AMENDMENT NO. 2 TO SCHEDULE 13D | 2021-12-30 | English | |
| SCHEDULE 13G | 2021-12-15 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2021-12-13 | English | |
| AMENDMENT NO. 1 TO SCHEDULE 13D | 2021-11-22 | English | |
| Regulatory Filings 2021 | 2021-11-17 | English | |
| ANNUAL REPORT | 2021-10-29 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 13329041 | AMENDMENT NO. 2 TO SCHEDULE 13D | 2021-12-30 | English | ||
| 13329042 | SCHEDULE 13G | 2021-12-15 | English | ||
| 13329043 | REPORT OF FOREIGN PRIVATE ISSUER | 2021-12-13 | English | ||
| 13329047 | AMENDMENT NO. 1 TO SCHEDULE 13D | 2021-11-22 | English | ||
| 13329044 | Regulatory Filings 2021 | 2021-11-17 | English | ||
| 13329045 | ANNUAL REPORT | 2021-10-29 | English | ||
| 13329046 | REPORT OF FOREIGN PRIVATE ISSUER | 2021-09-07 | English | ||
| 13329048 | CURRENT REPORT OF PRIVATE ISSUER | 2021-09-01 | English | ||
| 13329049 | REPORT OF FOREIGN PRIVATE ISSUER | 2021-08-20 | English | ||
| 13329050 | SCHEDULE 13D | 2021-07-27 | English | ||
| 13329051 | REPORT OF FOREIGN PRIVATE ISSUER | 2021-07-20 | English | ||
| 13329052 | PROSPECTUS | 2021-07-20 | English | ||
| 13329053 | Regulatory Filings 2021 | 2021-07-16 | English | ||
| 13329054 | Regulatory Filings 2021 | 2021-07-15 | English | ||
| 13329055 | FOR REGISTRATION OF CERTAIN CLASSES | 2021-07-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Regencell Bioscience Holdings Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30728/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30728 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30728 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30728 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30728}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Regencell Bioscience Holdings Ltd (id: 30728)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.